Posts

CBD for opioid withdrawal: Does it work? - Medical News Today

Image
Early studies suggest that cannabidiol (CBD), a compound in the cannabis plant, may help in the treatment of opioid withdrawal. A 2021 study reported that CBD may reduce anxiety and nausea, two symptoms that can occur during opioid withdrawal. The study also found that people with pain took less opioid medication when they were also receiving CBD. That said, health authorities have not approved CBD for use in opioid withdrawal. Also, CBD can cause side effects. Below, learn more about using CBD for opioid withdrawal, including more about its safety and how it compares with traditional treatments. People who take opioids consistently over a long period, then stop taking them abruptly can experience withdrawal symptoms. This is true regardless of whether a person is using the medication to treat pain, another health issue, or if they have opioid use disorder (OUD). The withdrawal symptoms can be debilitating, and they are generally the most intense for the first 1–2 weeks . However, the...

Biden’s New Covid Plan: Preparing for New Variants and Avoiding Shutdowns - The New York Times

Image
The strategy is supposed to help the nation transition to what some are calling a "new normal," but it will require funding from Congress. WASHINGTON — The White House unveiled its long-awaited new coronavirus response strategy on Wednesday, aimed at turning the corner on the worst public health crisis in a century while also preparing for the next threat. The plan, meant to help the United States transition to what some are calling a "new normal," has four main goals: protecting against and treating Covid-19; preparing for new variants; avoiding shutdowns; and fighting the virus abroad. But there is a big hitch: Much of the plan requires funding from Congress. The administration recently told congressional officials it could need as much as $30 billion to sustain the pandemic response. One outside adviser to the White House, Dr. Ezekiel Emanuel, said in an interview that the United States needed to spend much more — on the order of $100 billion over the next year, ...

Barham takes first in 5K festival event - Magnolia Banner News

Image
The weather was humid and the win was coming from the south. Other than those two factors, John Barham said he had a good run during the annual Magnolia Blossom Festival 5K event. "The first mile and a half was super easy, but I had a little bit of wind and the entire uphill on the way back," he said after finishing first in a time of 16 minutes and 35 seconds. Barham has a personal best time of 16 minutes and 11 seconds in the 5K. The recent 23-year-old La. Tech graduate (mechanical engineering degree), who is from Magnolia, ran his first Blossom Festival race in 2011 and he figures he's been running the event for about 11 years. Other than the wind and humidity, Barham said he had a good time competing in the event. "It was awesome to come out and have some fun at the Blossom Fesitival. I was told that there 256 runners with a total of 400 people signed up including the walkers," he mentioned. The race started at 7:30 p.m. near the corner of so...

Furosemide Seen as Safe for Preventing Newborn Lung Disease - Medscape

Image
A medication used to reduce fluid retention can also safely be used to prevent a dangerous lung condition that affects newborns, particularly those born premature, according to a new study. Furosemide (Lasix) — which can reduce excess fluid in the body caused by heart failure, liver disease, and kidney trouble — is commonly used off-label to prevent bronchopulmonary dysplasia (BPD), a disorder that causes irritation and poor development of lungs in premature infants. But until now, researchers have not studied its safety in this setting. BPD often affects babies born more than 2 months early and can sometimes result in breathing difficulties into adolescence and young adulthood. Dr Rachel Greenberg "There are so few drugs that have been tested for newborns and there are very little data to help neonatologists decide if certain medications are safe and effectiv...

Do Psychotropic Meds Raise or Lower COVID Risk? - Medscape

Image
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Different psychotropic medications are associated with different risks of COVID-19 in hospitalized patients with serious mental illness, a new study suggests. Investigators found that second-generation antipsychotics were associated with a 48% lower risk of COVID-19, while valproic acid was associated with a 39% increased risk of the disease "Exposures to several psychotropic medications were associated with risk of COVID-19 infection among inpatients with serious mental illness; decreased risk was observed with the use of second generation antipsychotics, with paliperidone use associated with the largest effect size. Valproic acid use was associated with an increased risk of infection," the investigators, led by Katlyn Nemani, MD, at NYU Langone Medical Center, New York, write. The study was published onlin...

Expert: Specialty Approvals Pharmacists Should Look for on the Horizon - Pharmacy Times

Image
Pharmacy Times interviewed Ray Tancredi, divisional vice president of Specialty Pharmacy, Development & Brand Rx/Vaccine Purchasing at Walgreens, on his presentation at Asembia Summit 2022 on specialty pharmaceutical pipeline updates. Question: In your session at Asembia, you break down the FDA pipeline into 4 categories: rare and orphan, specialty, gene therapy, and oncology. Upon assessment, have you noticed that breaking down the pipeline into these categories have helped to elucidate any current trends in the marketplace, and what might those trends be? Ray Tancredi: Over the years, I've had the opportunity to present this to the specialty pharmacy industry, and the audience could be pharmacists, it could be people from pharma, you have physicians, payers, and many folks interested in the pipeline. At one point, I used to put the presentation together, and it was in no particular order, sometimes it was in chronological order, but I think over time, what we found was p...

Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I–deficient and MHC I+ tumors | Proceedings of the National Academy of Sciences - pnas.org

[unable to retrieve full-text content] Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I–deficient and MHC I+ tumors | Proceedings of the National Academy of Sciences    pnas.org